STAT3 and neoplasm: In a cancer vaccine context, to overcome the tumor associated DC (TADC) dysfunction (i.e., poor responsiveness upon TLR stimulation), related to the hyperactivity of the STAT3 (signal transducer and activator of transcription 3), this team has encapsulated in the micelles a STAT3 siRNA [18] together with PIC and OVA.